Onocor Overview

  • Founded
  • 2014

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.27M

  • Investors
  • 3

Onocor General Information


Developer of catheter-based retrieval system designed to recover malposition cardiovascular devices. The company's system provides atrial septal closure devices, intravascular stents, aortic valve replacements, pulmonic valve replacements as well as mitral and tricuspid valve repair and replacement devices, enabling doctors to increase surgical accuracy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Surgical Devices
Primary Office
  • 3401 Grays Ferry Avenue
  • Building 212-120
  • Philadelphia, PA 19146-2701
  • United States
+1 (215) 000-0000

Onocor Timeline

Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Onocor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Jan-2020 $1.27M Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2019 Completed Generating Revenue
1. Grant 01-Jan-2018 $214K Completed Generating Revenue
To view Onocor’s complete valuation and funding history, request access »

Onocor Executive Team (1)

Name Title Board Seat Contact Info
Mark Piper Chief Executive Officer & President
To view Onocor’s complete executive team members history, request access »

Onocor Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
UPstart (Philadelphia) Accelerator/Incubator Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Onocor’s complete investors history, request access »